Wearable Technology in the Detection and Evaluation of Sleep-Related Breathing Disorders
NCT ID: NCT06606691
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
263 participants
OBSERVATIONAL
2025-02-18
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will analyze various variables related to sleep quality and quantity. Participants will be asked to wear a Xiaomi Mi Band 8 device during an overnight hospital polygraphy test, which will be conducted for one day in their usual daily environment. Additionally, at the beginning of their participation, they will need to complete a questionnaire collecting information about sociodemographic variables, daily habits, routines, and their assessment using the Epworth Sleepiness Scale.
After completing the polygraphy test and using the Xiaomi device, participants will be required to answer another questionnaire addressing aspects related to their sleep quality and habits during this period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Finger Wearable Device to Monitor Heart Rate Variability and Oxygen Saturation
NCT03268538
Vitoria Sleep Smart City: Interactive Intervention for Sleep Improvement
NCT05066581
Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients
NCT05485532
IntelligentCare: Wearable-based Intervention
NCT05777291
Actigraphy, Wearable EEG Band and Smartphone for Sleep Staging
NCT04943562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SRBD not only disrupts sleep but also increases the risk of chronic conditions like diabetes, hypertension, and strokes while creating an economic burden due to higher demand for medical resources. Their effects on physical and mental health lead to fatigue, reduced productivity, workplace accidents, and even disability, highlighting the need for more efficient diagnostic and management tools.
While polysomnography (PSG) is the gold standard for diagnosing sleep disorders, its high cost and invasive nature limit its accessibility. Wearable devices, such as wristbands and watches, offer a more accessible and non-invasive alternative, providing real-time data on sleep, heart rate, and activity. Though promising, these devices still require further research to confirm their accuracy in detecting SRBD. This project aims to evaluate the effectiveness of wearables as complementary tools in diagnosing and managing these disorders. Specifically, it has the following specific objectives: (1) To assess the accuracy, specificity, and sensitivity of wearable devices, such as wristbands and watches, in measuring blood oxygen saturation, heart rate, and activity, compared to nocturnal polygraphy. (2) To analyze the effectiveness of these devices in identifying individuals with potential sleep-related breathing disorders (SRBD) using unsupervised learning techniques. (3) To evaluate the impact and performance of an Artificial Intelligence model for detecting and classifying potential SRBD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nocturnal polygraphy study participants
This project aims to study approximately 263 individuals from different age groups and genders who are suspected of having sleep-related breathing disorders. The participants will be those referred for a nocturnal polygraphy study at the Sleep-Related Breathing Disorders and Home Ventilation Unit. During the polygraph test, participants will also wear the Xiaomi Mi Smart Band 8 wearable device to compare its accuracy in measuring sleep parameters, oxygen saturation, and heart rate against the polygraphy results.
Xiaomi Mi Smart Band 8
The wearable device, Xiaomi Mi Smart Band 8, will be used solely for observational purposes to assess its accuracy in measuring sleep parameters, oxygen saturation, and heart rate in comparison to nocturnal polygraphy. Participants are receiving routine care as prescribed by their clinicians, and the wearable device is not part of their medical treatment but is being observed alongside standard polygraphy tests.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xiaomi Mi Smart Band 8
The wearable device, Xiaomi Mi Smart Band 8, will be used solely for observational purposes to assess its accuracy in measuring sleep parameters, oxygen saturation, and heart rate in comparison to nocturnal polygraphy. Participants are receiving routine care as prescribed by their clinicians, and the wearable device is not part of their medical treatment but is being observed alongside standard polygraphy tests.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attend the Sleep Respiratory Disorders and Home Ventilation Unit for the polygraphy test.
Exclusion Criteria
* Present skin hypersensitivity or a known allergy to the material used in the covers or straps of the wearable devices that will be used as one of the measurement instruments in the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center on Information and Communication Technologies
OTHER
NeumoVigo I+i research group
UNKNOWN
Hospital Álvaro Cunqueiro
OTHER
TALIONIS research group
UNKNOWN
Universidade da Coruña
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patricia Concheiro Moscoso
Postdoctoral Research in CITIC-TALIONIS research group, Universidade da Coruña. Faculty of Health Sciences, Universidade da Coruña. PhD in Health Sciences.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Concheiro-Moscoso, PhD
Role: PRINCIPAL_INVESTIGATOR
CITIC-TALIONIS research group, Universidade da Coruña. Faculty of Health Sciences, Universidade da Coruña.
Mar Mosteiro-Añon, Physician
Role: PRINCIPAL_INVESTIGATOR
Hospital Álvaro Cunqueiro
José Alberto Fernández-Villar, PhD, Physician
Role: STUDY_CHAIR
NeumoVigo I+i. Hospital Álvaro Cunqueiro.
Javier Pereira, PhD
Role: STUDY_CHAIR
CITIC-TALIONIS research group, Universidade da Coruña. Faculty of Health Sciences, Universidade da Coruña.
María Luisa Torres-Durán, PhD, Physician
Role: STUDY_CHAIR
NeumoVigo I+i. Hospital Álvaro Cunqueiro.
Betania Groba, PhD
Role: STUDY_CHAIR
CITIC-TALIONIS research group, Universidade da Coruña. Faculty of Health Sciences, Universidade da Coruña.
Manuel Casal-Guisande, PhD
Role: STUDY_CHAIR
NeumoVigo I+i. Hospital Álvaro Cunqueiro.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain
Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Lujan MR, Perez-Pozuelo I, Grandner MA. Past, Present, and Future of Multisensory Wearable Technology to Monitor Sleep and Circadian Rhythms. Front Digit Health. 2021 Aug 16;3:721919. doi: 10.3389/fdgth.2021.721919. eCollection 2021.
de Zambotti M, Cellini N, Goldstone A, Colrain IM, Baker FC. Wearable Sleep Technology in Clinical and Research Settings. Med Sci Sports Exerc. 2019 Jul;51(7):1538-1557. doi: 10.1249/MSS.0000000000001947.
Gruwez A, Bruyneel AV, Bruyneel M. The validity of two commercially-available sleep trackers and actigraphy for assessment of sleep parameters in obstructive sleep apnea patients. PLoS One. 2019 Jan 9;14(1):e0210569. doi: 10.1371/journal.pone.0210569. eCollection 2019.
Perez-Pozuelo I, Zhai B, Palotti J, Mall R, Aupetit M, Garcia-Gomez JM, Taheri S, Guan Y, Fernandez-Luque L. The future of sleep health: a data-driven revolution in sleep science and medicine. NPJ Digit Med. 2020 Mar 23;3:42. doi: 10.1038/s41746-020-0244-4. eCollection 2020.
Espinosa MA, Ponce P, Molina A, Borja V, Torres MG, Rojas M. Advancements in Home-Based Devices for Detecting Obstructive Sleep Apnea: A Comprehensive Study. Sensors (Basel). 2023 Nov 30;23(23):9512. doi: 10.3390/s23239512.
Teplitzky TB, Zauher AJ, Isaiah A. Alternatives to Polysomnography for the Diagnosis of Pediatric Obstructive Sleep Apnea. Diagnostics (Basel). 2023 Jun 3;13(11):1956. doi: 10.3390/diagnostics13111956.
Concheiro-Moscoso P, Groba B, Alvarez-Estevez D, Miranda-Duro MDC, Pousada T, Nieto-Riveiro L, Mejuto-Muino FJ, Pereira J. Quality of Sleep Data Validation From the Xiaomi Mi Band 5 Against Polysomnography: Comparison Study. J Med Internet Res. 2023 May 19;25:e42073. doi: 10.2196/42073.
Hashimoto Y, Sakai R, Ikeda K, Fukui M. Association between sleep disorder and quality of life in patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2020 Jun 30;20(1):98. doi: 10.1186/s12902-020-00579-4.
Lyons MM, Bhatt NY, Pack AI, Magalang UJ. Global burden of sleep-disordered breathing and its implications. Respirology. 2020 Jul;25(7):690-702. doi: 10.1111/resp.13838. Epub 2020 May 21.
Kang JM, Kang SG, Cho SJ, Lee YJ, Lee HJ, Kim JE, Shin SH, Park KH, Kim ST. The quality of life of suspected obstructive sleep apnea patients is related to their subjective sleep quality rather than the apnea-hypopnea index. Sleep Breath. 2017 May;21(2):369-375. doi: 10.1007/s11325-016-1427-8. Epub 2016 Nov 4.
Chen L, Bai C, Zheng Y, Wei L, Han C, Yuan N, Ji D. The association between sleep architecture, quality of life, and hypertension in patients with obstructive sleep apnea. Sleep Breath. 2023 Mar;27(1):191-203. doi: 10.1007/s11325-022-02589-z. Epub 2022 Mar 23.
Morsy NE, Farrag NS, Zaki NFW, Badawy AY, Abdelhafez SA, El-Gilany AH, El Shafey MM, Pandi-Perumal SR, Spence DW, BaHammam AS. Obstructive sleep apnea: personal, societal, public health, and legal implications. Rev Environ Health. 2019 Jun 26;34(2):153-169. doi: 10.1515/reveh-2018-0068.
Borsoi L, Armeni P, Donin G, Costa F, Ferini-Strambi L. The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis. PLoS One. 2022 May 20;17(5):e0268677. doi: 10.1371/journal.pone.0268677. eCollection 2022.
Kaufmann CN, Susukida R, Depp CA. Sleep apnea, psychopathology, and mental health care. Sleep Health. 2017 Aug;3(4):244-249. doi: 10.1016/j.sleh.2017.04.003. Epub 2017 May 26.
K Pavlova M, Latreille V. Sleep Disorders. Am J Med. 2019 Mar;132(3):292-299. doi: 10.1016/j.amjmed.2018.09.021. Epub 2018 Oct 4.
Van Ryswyk E, Mukherjee S, Chai-Coetzer CL, Vakulin A, McEvoy RD. Sleep Disorders, Including Sleep Apnea and Hypertension. Am J Hypertens. 2018 Jul 16;31(8):857-864. doi: 10.1093/ajh/hpy082.
Tester NJ, Foss JJ. Sleep as an Occupational Need. Am J Occup Ther. 2018 Jan/Feb;72(1):7201347010p1-7201347010p4. doi: 10.5014/ajot.2018.020651.
Concheiro-Moscoso P, Pereira J, Mosteiro-Anon M, Torres-Duran M, Casal-Guisande M, Groba B. ReSTech project on Xiaomi wearable devices for monitoring and detecting obstructive sleep apnoea: observational study protocol. BMJ Open. 2025 Aug 13;15(8):e101824. doi: 10.1136/bmjopen-2025-101824.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/260
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.